Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects

Sibutramine-induced acute myocardial infarction in a young lady

(2009) Kin-Ming Anfernee Yim et al.   CLINICAL TOXICOLOGY

Sibutramine-Associated QT Interval Prolongation and Cardiac Arrest

(2008) David Ernest et al.   ANNALS OF PHARMACOTHERAPY

Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa

(2008) Corine Ekhart et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effect ofcytochrome P450 3A5*3genotype on the stereoselective pharmacokinetics of amlodipine in healthy subjects

(2008) Kyoung-Ah Kim et al.   CHIRALITY

The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance

(2008) KA Kim et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cytochrome P450 2B6 Catalyzes the Formation of Pharmacologically Active Sibutramine (N- -N,N-dimethylamine) Metabolites in Human Liver Microsomes

(2008) S. K. Bae et al.   DRUG METABOLISM AND DISPOSITION

Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects

(2008) Kyoung-Ah Kim et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Sibutramine: current status as an anti-obesity drug and its future perspectives

(2008) Bikash Sharma et al.   EXPERT OPINION ON PHARMACOTHERAPY

Effect of sibutramine HCl on cardiac hERG K+ channel

(2008) Ki-Suk Kim et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Sibutramine-associated adverse effects: a practical guide for its safe use

(2007) M. Florentin et al.   Obesity Reviews